Peter L. Toogood

4.9k total citations · 1 hit paper
55 papers, 3.6k citations indexed

About

Peter L. Toogood is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Peter L. Toogood has authored 55 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Organic Chemistry and 17 papers in Oncology. Recurrent topics in Peter L. Toogood's work include Cancer-related Molecular Pathways (12 papers), Insect Pest Control Strategies (6 papers) and Ubiquitin and proteasome pathways (6 papers). Peter L. Toogood is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Insect Pest Control Strategies (6 papers) and Ubiquitin and proteasome pathways (6 papers). Peter L. Toogood collaborates with scholars based in United States, United Kingdom and Belgium. Peter L. Toogood's co-authors include Patricia J. Harvey, Paul R. Keller, David W. Fry, William L. Elliott, Wilbur R. Leopold, Nancy Pryer, Xianxian Zheng, Mudher Albassam, Erin Trachet and Steven V. Ley and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Blood.

In The Last Decade

Peter L. Toogood

55 papers receiving 3.5k citations

Hit Papers

Specific inhibition of cyclin-dependent kinase 4/6 by PD ... 2004 2026 2011 2018 2004 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts
    2004 982 citations David W. Fry, Patricia J. Harvey et al. profile →

Peers

Peter L. Toogood
Sridhar K. Rabindran United States
Christopher L. Morton United States
Pier Giorgio Petronini Italy
Peter Traxler Switzerland
Roberta Alfieri Italy
Sophie Leclerc France
Taebo Sim South Korea
Gerd Bader Germany
A. Chaikuad Germany
Peter J. Worland United States
Sridhar K. Rabindran United States
Peter L. Toogood
Citations per year, relative to Peter L. Toogood Peter L. Toogood (= 1×) peers Sridhar K. Rabindran

Countries citing papers authored by Peter L. Toogood

Since Specialization
Citations

This map shows the geographic impact of Peter L. Toogood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter L. Toogood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter L. Toogood more than expected).

Fields of papers citing papers by Peter L. Toogood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter L. Toogood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter L. Toogood. The network helps show where Peter L. Toogood may publish in the future.

Co-authorship network of co-authors of Peter L. Toogood

This figure shows the co-authorship network connecting the top 25 collaborators of Peter L. Toogood. A scholar is included among the top collaborators of Peter L. Toogood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter L. Toogood. Peter L. Toogood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeomans, Larisa, et al.. (2024). Identification of a selective pyruvate dehydrogenase kinase 1 (PDHK1) chemical probe by virtual screening. European Journal of Medicinal Chemistry. 284. 117210–117210. 1 indexed citations
2.
Toogood, Peter L., Daniel J. Clauw, Sameer Phadke, & David L. Hoffman. (2021). Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?. Pharmacological Research. 165. 105465–105465. 43 indexed citations
3.
Toogood, Peter L.. (2017). Small molecule immuno-oncology therapeutic agents. Bioorganic & Medicinal Chemistry Letters. 28(3). 319–329. 20 indexed citations
4.
Hu, Xiao, Yahong Wang, Ling-Yang Hao, et al.. (2015). Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists. Nature Chemical Biology. 11(2). 141–147. 176 indexed citations
5.
Toogood, Peter L.. (2008). Mitochondrial drugs. Current Opinion in Chemical Biology. 12(4). 457–463. 61 indexed citations
6.
Baughn, Linda B., Maurizio Di Liberto, Kaida Wu, et al.. (2006). A Novel Orally Active Small Molecule Potently Induces G1 Arrest in Primary Myeloma Cells and Prevents Tumor Growth by Specific Inhibition of Cyclin-Dependent Kinase 4/6. Cancer Research. 66(15). 7661–7667. 172 indexed citations
7.
Toogood, Peter L.. (2005). The Kinome Is Not Enough. Chemistry & Biology. 12(10). 1057–1058. 4 indexed citations
8.
Bathini, Yadagiri, Inderjit Singh, Patricia J. Harvey, et al.. (2005). 2-Aminoquinazoline inhibitors of cyclin-dependent kinases. Bioorganic & Medicinal Chemistry Letters. 15(17). 3881–3885. 20 indexed citations
9.
Toogood, Peter L.. (2002). Progress toward the development of agents to modulate the cell cycle. Current Opinion in Chemical Biology. 6(4). 472–478. 43 indexed citations
10.
Toogood, Peter L.. (2001). Cyclin‐dependent kinase inhibitors for treating cancer. Medicinal Research Reviews. 21(6). 487–498. 76 indexed citations
11.
Barvian, Mark R., Diane H. Boschelli, Ellen M. Dobrusin, et al.. (2001). Pyrido[2,3-d]pyrimidin-7-one Inhi-bitors of Cyclin-Dependent Kinases.. Journal of Medicinal Chemistry. 44(6). 1016–1016. 2 indexed citations
12.
Barvian, Mark R., Diane H. Boschelli, Ellen M. Dobrusin, et al.. (2000). Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases. Journal of Medicinal Chemistry. 43(24). 4606–4616. 130 indexed citations
13.
Beidler, David, Deepika Ahuja, Max S. Wicha, & Peter L. Toogood. (1999). Inhibition of protein synthesis by didemnin B is not sufficient to induce apoptosis in human mammary carcinoma (MCF7) cells. Biochemical Pharmacology. 58(6). 1067–1074. 24 indexed citations
14.
Vera, Matthew D., et al.. (1998). Synthesis and biological activity of [Tic5] didemnin B. Bioorganic & Medicinal Chemistry Letters. 8(24). 3653–3656. 15 indexed citations
15.
Toogood, Peter L., et al.. (1996). Synthesis of an Enantiomerically Pure Serine-Derived Thiazole. The Journal of Organic Chemistry. 61(22). 7671–7676. 19 indexed citations
16.
Toogood, Peter L., et al.. (1995). Mechanism of Protein Synthesis Inhibition by Didemnin B in Vitro. Biochemistry. 34(28). 9177–9184. 61 indexed citations
17.
Toogood, Peter L., et al.. (1995). Enzyme-Catalyzed Regioselective Hydrolysis of Aspartate Diesters. The Journal of Organic Chemistry. 60(24). 8110–8112. 13 indexed citations
18.
Toogood, Peter L., et al.. (1995). ChemInform Abstract: Synthetic Studies Towards Keramamide F.. ChemInform. 26(20). 1 indexed citations
19.
Toogood, Peter L., et al.. (1991). Monovalent sialosides that bind tightly to influenza A virus. Journal of Medicinal Chemistry. 34(10). 3138–3140. 52 indexed citations
20.
Blaney, W. M., Monique S. J. Simmonds, Steven V. Ley, James C. Anderson, & Peter L. Toogood. (1990). Antifeedant effects of azadirachtin and structurally related compounds on lepidopterous larvae. Entomologia Experimentalis et Applicata. 55(2). 149–160. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sridhar K. Rabindran Breakdown of academic impact, for papers by Christopher L. Morton Breakdown of academic impact, for papers by Pier Giorgio Petronini Breakdown of academic impact, for papers by Peter Traxler Breakdown of academic impact, for papers by Roberta Alfieri Breakdown of academic impact, for papers by Sophie Leclerc Breakdown of academic impact, for papers by Taebo Sim Breakdown of academic impact, for papers by Gerd Bader Breakdown of academic impact, for papers by A. Chaikuad Breakdown of academic impact, for papers by Peter J. Worland
Rankless by CCL
2026